Self-Glucose Monitoring Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Self-Glucose Monitoring Market covers analysis By Product (Test strips, Lancets, Blood Glucose meters); End-user (Homes, Hospitals, Diagnostic centers); Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00027667
  • Category : Medical Device
  • No. of Pages : 150

Self-Glucose Monitoring Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET OVERVIEW
Diabetic -patients can use blood glucose monitoring to help them make daily management decisions like food consumption, insulin dose, and physical activity. Patients use blood glucose meters to check their glucose levels quickly and provide an accurate measure of capillary glucose concentration. Self-monitoring blood glucose is a modern diabetes management procedure that involves the use of blood glucose by patients to check their glucose levels quickly and provide an accurate measure of capillary glucose concentration. To accomplish long-term glycemic management, SMBG technology employs test strips, lancets, and blood glucose meters. Patients who take insulin must monitor their blood glucose level in order to alter insulin doses or change medications as needed which can only be done with the use of self-monitoring blood glucose devices.

MARKET SCOPE
The Self-Glucose Monitoring Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Self-Glucose Monitoring Market with detailed market segmentation by product, application, end-user, and geography. The report provides key statistics on the market status of the leading players and offers key Self-Glucose Monitoring Market trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on the product, the market is segmented into Test Strips, Lancets, Blood Glucose Meters.
  •  On the basis of end-user, the market is bifurcated hospitals and Homes, Diagnostic centers.
  •  By Application, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes.

MARKET DYNAMICS
Drivers:

  •  The rise in demand for non-invasive blood glucose meters.
  •  Advances in the field of blood glucose monitoring systems.
  •  Increase in the geriatric population.

Restraints:

  •  Reduced accuracy due to differences in strip manufacture, strip storage, and aging.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. Self-Glucose Monitoring Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social, and technological factors affecting the Self-Glucose Monitoring Market in these regions.

IMPACT OF COVID-19 ON Self- Glucose Monitoring MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions.

Self-Glucose Monitoring Market Report Analysis

Self-Glucose Monitoring Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Abbott Laboratories
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd.
  • Bayer.AG
  • Lifescan,Inc.
  • Dexcom, Inc.
  • Sanofi
  • Elly Elly and Company
  • B.Braun Melsungen AG

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Product
  • Test strips
  • Lancets
  • Blood Glucose meters
Market Segment By End-user
  • Homes
  • Hospitals
  • Diagnostic centers
Market Segment By Application
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

The report covers key developments in the Self-Glucose Monitoring Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and part partnerships Collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players from the Self-Glucose Monitoring Market are anticipated to have lucrative growth opportunities in the future with the rising Self-Glucose Monitoring Market in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Self-Glucose Monitoring Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Abbott Laboratories
  •  Medtronic plc
  •  F. Hoffmann-La Roche Ltd.
  •  Bayer.AG
  •  Lifescan,Inc.
  •  Dexcom, Inc.
  •  Sanofi
  •  Elly Elly and Company
  •  B.Braun Melsungen AG
  •  Arkray,Inc.

    Self-Glucose Monitoring Market Report Scope

    Report Attribute Details
    Market size in 2023 US$ XX Million
    Market Size by 2031 US$ XX Million
    Global CAGR (2023 - 2031) XX%
    Historical Data 2021-2022
    Forecast period 2024-2031
    Segments Covered By Product
    • Test strips
    • Lancets
    • Blood Glucose meters
    By End-user
    • Homes
    • Hospitals
    • Diagnostic centers
    By Application
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Gestational Diabetes
    Regions and Countries Covered North America
    • US
    • Canada
    • Mexico
    Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
    South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America
    Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
    Market leaders and key company profiles
    • Abbott Laboratories
    • Medtronic plc
    • F. Hoffmann-La Roche Ltd.
    • Bayer.AG
    • Lifescan,Inc.
    • Dexcom, Inc.
    • Sanofi
    • Elly Elly and Company
    • B.Braun Melsungen AG
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

This text is related
to segments covered.

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

This text is related
to country scope.

The List of Companies

- Abbott Laboratories
- Medtronic plc
- F. Hoffmann-La Roche Ltd.
- Bayer.AG
- Lifescan,Inc.
- Dexcom, Inc.
- Sanofi
- Elly Elly and Company
- B.Braun Melsungen AG
- Arkray,Inc.

Trends and growth analysis reports related to Medical Device : READ MORE..